MEDIA
ASCII HealthTech: Using “living cells”, Metcela is developing an alternative heart failure therapy | Metcela Inc.
ASCII HealthTech wrote an article about Metcela on 10th October, 2018 (Japanese)
-
NEWS
-
PRESS RELEASE
Metcela and Nagoya University to Collaborate in Research to Accelerate the Development of Regenerative Medicine
-
NEWS
Metcela Received the Best Research Award at the Well-being & Age-Tech 2022 Award
-
PRESS RELEASE
Metcela eligible to receive up to $7 Million (1 Billion JPY) AMED Grant for Promoting the Development of Regenerative Medicine Product Using Cardiac Stem Cells